NCT03536039
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Ospedale San Raffaele Milan, Italy
Clinical trial condition
Lymphoma, Large B-Cell, Diffuse
Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.
59 public trials
6 recruiting studies
Lymphoma, Large B-Cell, Diffuse trial results
NCT03682796
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- Banner MD Anderson Gilbert, Arizona, United States
- Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT02883517
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- University Hospital of Bordeaux - Hospital Saint André Bordeaux, France
Completed
Translational Study of Molecular Classification of Relapsed/Refractory Diffuse Large B-cell Lymphoma
NCT05318391
- Conditions
- Gene Expression Profiling, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Yian Zhang Shanghai, Shanghai Municipality, China
Completed
Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma
NCT02086604
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
- Ohio State University, James Cancer Hospital Columbus, Ohio, United States
NCT02987400
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- UK Graz: Universitätsklinik für Innere Medizin; Klinische Abteilung für Hämatologie Graz, Austria
- Medizinische Universität Innsbruck Univ.-Klinik für Innere Medizin V Hämatologie und Onkologie Innsbruck, Austria
- Kepler Universitätsklinikum Linz, Med Campus III.,Univ.-Klinik für Hämatologie und Internistische Onkologie Linz, Austria
- Universitätsklinik für Innere Med. III, PMU Salzburg Salzburg, Austria
NCT04317313
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
NCT02669017
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Burkitt's Lymphoma, +39 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
- Washington University School of Medicine St Louis, Missouri, United States
NCT02181218
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +12 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
- Washington University School of Medicine St Louis, Missouri, United States
NCT02343536
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- University of Chicago Chicago, Illinois, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States